More than 6 authors are listed because this complex high altitude research expedition required a great amount of work, the successful accomplishment of which could not have been achieved by fewer researchers. All authors contributed substantially to the study.
Introduction
Traveling to high altitudes for recreational reasons is becoming increasingly popular and has been a subject of scientific interest ever since. Technical progress enables researchers to gain new insights into changes that occur within the human body upon exposure to natural hypobaric atmospheric conditions. Intraocular pressure (IOP) changes at high altitudes have been the subject of several publications [1] [2] [3] [4] [5] [6] [7] [8] [9] . Yet results have been inconsistent. Findings range from a decrease 1, 4, 6, 8, 9 through unchanged 5 , to an increase 1 in IOP at moderate to high altitudes. Changes in intraocular pressure during an expedition to very high altitudes, i.e. more than 5500m/18045ft, have not
been documented yet.
Depending on the degree of hypoxia 10 , ascent rate 11 and individual susceptibility 12 , acute mountain sickness or even the less common high altitude cerebral edema (HACE) may occur.
HACE results in increased intracerebral pressure (ICP) and hence in cerebral hypoperfusion with possible severe and fatal dysfunction 13 . Several studies suggest that a rise in ICP leads to an increase in IOP, and thus that IOP measurement could be a minimally invasive method to detect a rise in ICP [14] [15] [16] . Therefore, a correlation of IOP with parameters indicating cerebral affection due to hypoxia would be of great interest.
The Muztagh Ata medical research expedition study included researchers from various medical specialties, such as pneumology, neurology, hematology and ophthalmology, in a holistic approach to prospectively assess hypoxia induced changes of the body. A list of the discipline specific studies along with references can be found in Table 1 . We set out to investigate changes in IOP at very high altitudes (>6000m/19685ft) with two different ascent profiles and place these results into perspective with simultaneously occurring ophthalmic and systemic changes (e.g. optic disc status, cerebral acute mountain sickness scores including possible HACE, pulse oximetry).
Methods
Our working hypothesis was that IOP would decrease with altitude due to lower systemic oxygen saturation and decreased aqueous production.
Volunteers
This randomized, prospective, multidisciplinary, observational cohort study [17] [18] [19] [20] was performed within the scope of a high altitude medical research expedition on Mt. Muztagh Ata (7546m/24751 ft), Fig. 1 . Mountaineers in good physical shape were included. Exclusion criteria were any type of ocular, cardiac or respiratory disease or history of high altitude pulmonary edema or high-altitude cerebral edema, history of ophthalmic disease or ophthalmic surgery (including cataract), contact lens wearers and intake of drugs other than non-steroidal antirheumatic agents during the expedition. The study was approved by the Ethical Committee of the University Hospital, Zurich, and adheres to the tenets of the Declaration of Helsinki (1983 revision). Informed, written consent was obtained from all subjects prior to the examinations.
Ascent profile
For security reasons and in order to study the effect of acclimatization, the participants were randomly distributed into two groups with different ascent profiles ( Fundus photographs were acquired using a handheld digital fundus camera (Genesis-D, Kowa
Inc., Tokyo, Japan). Photographs were analyzed by three independent ophthalmologists. Optic discs were graded being either not swollen, equivocal, or swollen 17 .
Measurements were performed after one night of acclimatization 19 at similar times of day in order to minimize the effect of strenuous exercise 21 and diurnal variation 22 .
Cerebral acute mountain sickness (AMS-c) scores on the Environmental Symptoms
Questionnaire III 23 were assessed daily during the expedition. The AMS 
Statistical analysis
Statistical analysis was performed with commercially available statistical software packages (SPSS 13, SPSS Inc., Chicago, IL, USA and Statistica 6, Statsoft INC, Tulsa, OK). Test for normal distribution was performed using the Kolmogorov-Smirnov test. Measurements at each altitude between the two groups were compared using the unpaired Student's t-test (inlcuding Welch-correction). Repeated measures analysis of variance (ANOVA) was performed with combined data of groups 1 and 2 to assess changes in IOP over the different altitudes.
Assumption of sphericity was assessed using Mauchly's test. In case of a statistically significant result, post-hoc testing with Bonferroni's correction was applied.
Multiple regression analysis was used to analyze correlations between IOP as the dependent variable and independent variables (ascent group and different times of acclimatization, SaO 2 , cerebral acute mountain sickness (AMS-c) score, central corneal thickness (CCT), altitude, optic disc appearance) and age. The time of acclimatization was defined as the amount of days during the expedition starting from Subash. Correlation between environmental temperature and IOP as well as pachymetry and IOP was analyzed using bivariate regression analysis. Normally distributed data are presented as mean ± standard deviation (SD), not-normally distributed data are expressed as median and range (minimum and maximum). A two sided -error (p-value) of less than 0.05 was considered statistically significant.
Results
Seven out of a total of 32 climbers included in the ophthalmic branch of the study were excluded because of either incomplete data collection during the expedition (n=4), a history of refractive surgery on both eyes (LASIK, n=1) or due to drug intake during the examination period (n=2).
Of the 25 climbers included, 5 were female and 20 male. Mean age in groups 1 and 2 were 42±12 years and 45±9 years, respectively, without a significant difference between groups (p=0.54). 17 mountaineers (9 in group 1 (Gr1), 8 in group 2 (Gr2)) reached the summit.
Intraocular pressures in both ascent groups increased from ZH to C1 and then continuously decreased while further ascending to C2, re-descending to BC2 as shown in Table 2 . Maximum IOP measurements never exceeded 21mmHg in both groups. Due to logistic reasons, group 1 could not be examined at BC2. No significant differences between ascent groups were found at any altitude (ZH p=0.78, BC1 p=0.77, C1 p=0.65, C2 p=0.82). Thus for further analyses, measurements of both groups were combined. Mean IOP changes for both groups are shown in Central corneal thickness increased from 537 to 572 m in group 1 and from 534 to 563 m in group 2 with increasing altitude and decreased after decent 20 . Oxygen saturation (SaO 2 ) measurements, and AMS-c scores are shown in Table 3 . IOP measurements were undertaken in the same windless tent with temperatures varying from 9° (minimum temperature at C2) to 37°
(maximum temperature at BC) Celsius during the day with a mean of 21°C±7. Secondly, IOP correlated with oxygen saturation at various altitudes.
Our findings for the initial but statistically insignificant increase in IOP at 4497m/14750ft
parallel the results of Somner et al. 1 . Thereafter, the decline in IOP at further ascent to higher altitudes (at 6265m/20549ft), at which severe systemic hypoxia occurs, may be due to depleted oxygen supply to the non-pigmented ciliary epithelium and hence to decreased aqueous humor production. Aqueous production seems to become impaired after a certain systemic hypoxia threshold has been reached, which is supported by the statistically significant negative correlation between oxygen saturation in the participants at various heights and their IOP. The pathophysiology behind this phenomenon may be comparable to that reported in other conditions with impaired oxygen supply to the ciliary body such as in ocular ischemic syndrome 24 . or in severe cases of giant cell arteritis 25 .
The rationale behind randomizing the climbers into two groups with different ascent profiles was to assess differences in the measured parameters which may have been due to distinct acclimatization times. Safety reasons also played a role in keeping the ascent groups limited.
Duration between examinations at BC1 and C2 was seven days in group 1 and eleven days in group 2 (see Fig. 2 ). As no significant differences in the IOP values in the ascent groups were found, the differences in acclimatization time might have been too little to detect IOP behavior changes between the two groups. IOP reduction over time did occur, however, and a significant negative correlation between acclimatization time and IOP measurements was found in our analysis. Pressures at BC2 (4497m), 13 days after having climbed to substantially higher altitudes following the initial measurements, were significantly lower than the ones at the same altitude (BC1). Thus, hypoxia during a prolonged stay at high altitudes may also lead to reduced aqueous production and therefore to the decline in intraocular pressure measured at 6250m (C2) 1, 26 . But overall, the duration of systemic hypoxia seems to play a greater role in IOP reduction compared to the extent of hypoxia. Yet, from the current data, no estimation can be made upon the amount of contribution of acclimatization towards IOP reduction.
No statistically significant correlation was found between IOP and optic disc swelling or AMS-c scores. As reported earlier 27 , a high incidence of optic disc swelling has been observed in more than half of our volunteers with increasing altitude, representing increasingly severe hypoxia. All evidence pointed towards hypoxia-induced increase in brain volume as the most probable etiology of the optic disc swelling, with a potential consecutive increase in intracranial pressure (ICP). Several studies support the hypothesis that a rise in ICP leads to an increase in IOP. Thus IOP measurement could be used as a minimally invasive method to detect a raise in ICP [14] [15] [16] .
Other investigators 28, 29 , found no correlation between IOP and optic disc swelling, i.e. a rise in ICP. Nevertheless, due to the small changes in IOP noted at different altitudes, which were clinically insignificant, we suggest that measuring the IOP in climbers at high altitudes is not an appropriate method to detect an increase in ICP.
In addition, acute strenuous exercise is known to lower the IOP 21 . However, 10 minutes after stopping the exercise, Price et al. detected no significant IOP difference to baseline data 21 . Our participants were examined on the day following ascent to a new high camp, thus allowing for at least 15 hours of rest. Based on the study design with moderate ascent rate, the influence of physical exercise should have been minimal on all our measured parameters.
IOP readings are largely influenced by mechanical properties of the eye. These properties may be altered by the development of corneal edema and are neither linear nor measurable to date 30, 31 . Previous reports indicate a greater accuracy in IOP measurements by the TonopenXL on edematous corneas [32] [33] [34] . In normal corneas, the TonoPenXL has been shown to be least affected by CCT when comparing it to other transportable handheld tonometers 35 . Due to its portability and ease of use, we chose the lightweight TonopenXL for our expedition. Concerning temperature variations during the expedition, especially low temperatures that may decrease battery voltage output, the manual of the Tonopen XL explicitely states, that in the event of low battery output, the diplay shows the letters "LoB". In the situation of low temperature, that may affect the transducer, the device may be inactivated or the calibration process may be slowed down. During our expedition, no such events occurred.
Measuring IOP in such conditions as in a low temperature environment, can alter the measurement results by causing a decrease in episcleral venous pressure 36 . There was no correlation between temperature and IOP measurements at any altitude in this study.
As shown in our study, changes in IOP during very high altitude mountaineering are small and insignificant from a clinical point of view, which is in conjunction with previous studies. In essence, exposure to very high altitudes results in a slight decrease in IOP. Considering our data from the highest IOP examinations to date, in addition to already existing data, we conclude that measuring the IOP is not a useful screening method for incipient and potentially harmful altitude-dependent diseases. In summary, in healthy persons climbs to very high altitudes seem to be safe with regard to intraocular pressure changes. Table 1 : Overview of the of the discipline specific studies. The first column denotes the discipline, the second column the title of the studies performed and the third column lists the respective reference. 
